Cavalli F - Search Results

1

Epirubicin in colorectal cancer. A phase II study of the early clinical trials group (EORTC).

Holdener EE, Hansen HH, Høst H, Bruntsch U, Cavalli F, Renard J, Pinedo HM, Rozencweig M. Holdener EE, et al. Among authors: cavalli f. Invest New Drugs. 1985;3(1):63-6. doi: 10.1007/BF00176826. Invest New Drugs. 1985. PMID: 3857219

2

TCNU (LS 2667), a new active drug in the treatment of advanced colorectal cancer. EORTC Early Clinical Trials Group.

Gundersen S, Dombernowsky P, Cavalli F, Bruntsch U, Renard J, Van Glabbeke M, Pinedo H. Gundersen S, et al. Among authors: cavalli f. Eur J Cancer Clin Oncol. 1989 Jul;25(7):1095-7. doi: 10.1016/0277-5379(89)90394-5. Eur J Cancer Clin Oncol. 1989. PMID: 2759163

3

A phase II study of spirogermanium in patients with advanced malignant lymphoma.

Sessa C, ten Bokkel Huinik W, Clavel M, Lev LM, Joss RA, Renard J, Cavalli F. Sessa C, et al. Among authors: cavalli f. Invest New Drugs. 1989 Jul;7(2-3):219-22. doi: 10.1007/BF00170861. Invest New Drugs. 1989. PMID: 2793376

4

Iproplatin and carboplatin induced toxicities: overview of phase II clinical trial conducted by the EORTC Early Clinical Trials Cooperative Group (ECTG).

van Glabbeke M, Renard J, Pinedo HM, Cavalli F, Vermorken J, Sessa C, Abele R, Clavel M, Monfardini S. van Glabbeke M, et al. Among authors: cavalli f. Eur J Cancer Clin Oncol. 1988 Feb;24(2):255-62. doi: 10.1016/0277-5379(88)90262-3. Eur J Cancer Clin Oncol. 1988. PMID: 3281842

5

Randomized phase II trial of carminomycin versus 4'-epidoxorubicin in advanced breast cancer.

Rozencweig M, ten Bokkel Huinink W, Cavalli F, Bruntsch U, Dombernowsky P, Høst H, Bramwell V, Renard G, Van Glabbeke M, Decoster G. Rozencweig M, et al. Among authors: cavalli f. J Clin Oncol. 1984 Apr;2(4):275-81. doi: 10.1200/JCO.1984.2.4.275. J Clin Oncol. 1984. PMID: 6584561 Clinical Trial.

6

Phase II trial of diaziquone (AZQ) in advanced malignant melanoma.

Høst H, Joss R, Pinedo H, Bruntsch U, Cavalli F, Renard G, van Glabbeke M, Rozencweig M. Høst H, et al. Among authors: cavalli f. Eur J Cancer Clin Oncol. 1983 Feb;19(2):295-8. doi: 10.1016/0277-5379(83)90430-3. Eur J Cancer Clin Oncol. 1983. PMID: 6681775

7

Phase II study of amsacrine in solid tumors: a report of the EORTC Early Clinical Trial-Group.

De Jager R, Siegenthaler P, Cavalli F, Klepp O, Bramwell V, Joss R, Alberto P, van Glabbeke M, Renard J, Rozencweig M, Hansen HH. De Jager R, et al. Among authors: cavalli f. Eur J Cancer Clin Oncol. 1983 Feb;19(2):289-93. doi: 10.1016/0277-5379(83)90429-7. Eur J Cancer Clin Oncol. 1983. PMID: 6687457

8

Phase II study of 5'-deoxy-5-fluorouridine (doxifluridine) in advanced malignant melanoma.

Alberto P, Rozencweig M, Clavel M, Siegenthaler P, Cavalli F, Gundersen S, Bruntsch U, Renard J, Pinedo H. Alberto P, et al. Among authors: cavalli f. Cancer Chemother Pharmacol. 1986;16(1):78-9. doi: 10.1007/BF00255292. Cancer Chemother Pharmacol. 1986. PMID: 2933177

9

Phase II study of iproplatin in advanced ovarian carcinoma.

Sessa C, Vermorken J, Renard J, Kaye S, Smith D, ten Bokkel Huinink W, Cavalli F, Pinedo H. Sessa C, et al. Among authors: cavalli f. J Clin Oncol. 1988 Jan;6(1):98-105. doi: 10.1200/JCO.1988.6.1.98. J Clin Oncol. 1988. PMID: 3335895

10

Phase II study of doxifluridine in advanced colorectal adenocarcinoma.

Abele R, Alberto P, Kaplan S, Siegenthaler P, Hofmann V, Ryssel HJ, Hartmann D, Holdener EE, Cavalli F. Abele R, et al. Among authors: cavalli f. J Clin Oncol. 1983 Dec;1(12):750-4. doi: 10.1200/JCO.1983.1.12.750. J Clin Oncol. 1983. PMID: 6230419

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

642 results

Search Page

Filters